about
Insights into Soluble Toll-Like Receptor 2 as a Downregulator of Virally Induced InflammationTrappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:CMilk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammationAnti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation.Soluble toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection.Protein Digestion of Baby Foods: Study Approaches and Implications for Infant Health.Breastfeeding Behaviors and the Innate Immune System of Human Milk: Working Together to Protect Infants against Inflammation, HIV-1, and Other Infections.Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants.Elevated Fecal pH Indicates a Profound Change in the Breastfed Infant Gut Microbiome Due to Reduction of Bifidobacterium over the Past Century.Effects of Human Leukocyte Antigen Class I Genetic Parameters on Clinical Outcomes and Survival after Initiation of Highly Active Antiretroviral TherapyMolecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive IndividualsUse of UV Treated Milk Powder to Increase Vaccine Efficacy in the ElderlyPeptidomic and glycomic profiling of commercial dairy products: identification, quantification and potential bioactivitiesColonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants
P50
Q26741112-3FA870AD-2FC1-441B-863C-84F08E81AFE3Q34251265-4AAE8BAE-3DC5-407D-8253-1526A9589FD8Q34335961-4FF0100C-1651-43FE-88BA-9955B1B32EB6Q34541093-F4FB8291-A838-4AE1-BE43-FBE2414B6C34Q35970108-C941DDAC-384D-4985-B753-F903953050A4Q38952369-7E653FEB-2781-457F-82E0-A6988EED2095Q44151075-62A5FB27-62AF-4C8E-A0D8-B2E202D42281Q45987785-558CB04B-4326-4845-AB72-20C253A35A66Q46515638-EA168E8B-C948-4208-9989-5C85C165B1D1Q51736799-A54950B1-B9B6-4BCE-ADDA-155C202FED8DQ57200834-A5C01FEA-D180-49DA-9342-88F1BD25B7BFQ57200837-242154E5-7A76-4B8D-BF84-B6AF7304EC78Q58606360-B21AAAD9-FDC1-426E-8E33-0269A809A41BQ91868897-003FD5FC-5661-4221-B2F3-FE3195BFBAB4Q92822623-F30EEE0E-991C-44CC-B363-16CE3ABB6B50
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bethany M. Henrick
@ast
Bethany M. Henrick
@en
Bethany M. Henrick
@es
Bethany M. Henrick
@nl
Bethany M. Henrick
@sl
type
label
Bethany M. Henrick
@ast
Bethany M. Henrick
@en
Bethany M. Henrick
@es
Bethany M. Henrick
@nl
Bethany M. Henrick
@sl
prefLabel
Bethany M. Henrick
@ast
Bethany M. Henrick
@en
Bethany M. Henrick
@es
Bethany M. Henrick
@nl
Bethany M. Henrick
@sl
P106
P1153
9274829100
P31
P496
0000-0003-1883-6749